Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?

Liquid biopsies are the detection of molecular information in fluids from patients with cancer. In colorectal cancer (CRC), the most promising liquid biopsy strategy is the use of circulating tumor DNA (ctDNA) from plasma. In early-stage CRC, the potential for ctDNA to impact care stems from the det...

Descripción completa

Detalles Bibliográficos
Autores principales: Solar Vasconcelos, Joao Paulo, Boutin, Melina, Loree, Jonathan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Liquid Biopsy in Gastrointestinal Cancers: circulating tumor DNA (ctDNA) and circulating tumor cell (CTC)-based precision oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772953/
https://www.ncbi.nlm.nih.gov/pubmed/36570410
http://dx.doi.org/10.1177/17588359221143975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772953/
https://www.ncbi.nlm.nih.gov/pubmed/36570410
http://dx.doi.org/10.1177/17588359221143975

Ejemplares similares